- Home
- ZUMZ vs BNTC Comparison
ZUMZ vs BNTC Comparison
Compare ZUMZ & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZUMZ | BNTC |
|---|---|---|
| Founded | 1978 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 421.7M | 371.0M |
| IPO Year | 2005 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ZUMZ | BNTC |
|---|---|---|
| Price | $22.46 | $11.39 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $18.00 | ★ $27.67 |
| AVG Volume (30 Days) | 118.3K | ★ 159.4K |
| Earning Date | 01-01-0001 | 05-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 97.23 | 80.94 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $889,202,000.00 | N/A |
| Revenue This Year | $6.33 | N/A |
| Revenue Next Year | $1.90 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1.57 | N/A |
| 52 Week Low | $11.31 | $9.85 |
| 52 Week High | $31.70 | $17.15 |
Technical Indicators
Market Signals| Indicator | ZUMZ | BNTC |
|---|---|---|
| Relative Strength Index (RSI) | 35.37 | 51.96 |
| Support Level | $21.19 | $11.30 |
| Resistance Level | $22.96 | $12.75 |
| Average True Range (ATR) | 1.17 | 0.73 |
| MACD | -0.24 | 0.07 |
| Stochastic Oscillator | 8.74 | 90.34 |
Price Performance
Historical ComparisonAbout ZUMZ Zumiez Inc.
Zumiez Inc is a United-States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art from action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.